Drugs / G2SCID
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03311503 | Feb 2018 → Jan 2028 expected | combined immunodeficiency, X-linked | David Williams | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G2SCID | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03311503 ↗ |